{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:53:07Z","timestamp":1791175987400,"version":"4.1.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2746,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL090036"],"award-info":[{"award-number":["HL090036"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.exphem.2014.09.006","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T11:19:51Z","timestamp":1411903191000},"page":"995-1012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia"],"prefix":"10.1016","volume":"42","author":[{"given":"Bin E.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2014.09.006_bib1","first-page":"1497","article-title":"A minute chromosome in human chronic granulocytic leukemia","volume":"132","author":"Nowell","year":"1960","journal-title":"Science"},{"key":"10.1016\/j.exphem.2014.09.006_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","article-title":"Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22","volume":"36","author":"Groffen","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0308-2261(21)00164-8","article-title":"Ph1-positive leukaemia, including chronic myelogenous leukaemia","volume":"9","author":"Rowley","year":"1980","journal-title":"Clin Haematol"},{"key":"10.1016\/j.exphem.2014.09.006_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"Lugo","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.exphem.2014.09.006_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0092-8674(92)90602-9","article-title":"Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias","volume":"71","author":"Tkachuk","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0092-8674(92)90603-A","article-title":"The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene","volume":"71","author":"Gu","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ng1092-113","article-title":"A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias","volume":"2","author":"Djabali","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2014.09.006_bib8","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1073\/pnas.90.16.7884","article-title":"Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product","volume":"90","author":"Domer","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2014.09.006_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.leu.2404578","article-title":"Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement","volume":"21","author":"Jansen","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.09.006_bib10","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1182\/blood-2013-02-474833","article-title":"Recent progress toward epigenetic therapies: the example of mixed lineage leukemia","volume":"121","author":"Neff","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib11","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1093\/emboj\/18.13.3564","article-title":"The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis","volume":"18","author":"Dobson","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2014.09.006_bib12","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1093\/emboj\/16.14.4226","article-title":"Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL","volume":"16","author":"Lavau","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2014.09.006_bib13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0092-8674(00)81269-6","article-title":"An MLL-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes","volume":"85","author":"Corral","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/MCB.18.1.122","article-title":"The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX","volume":"18","author":"Slany","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2014.09.006_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/emboj\/19.5.843","article-title":"Tumorigenesis in mice with a fusion of the leukaemia oncogene MLL and the bacterial lacZ gene","volume":"19","author":"Dobson","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2014.09.006_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","article-title":"The pathogenesis of mixed-lineage leukemia","volume":"7","author":"Muntean","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.exphem.2014.09.006_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1182\/blood-2005-08-3498","article-title":"A murine MLL-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy","volume":"108","author":"Chen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib18","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1038\/sj.onc.1209636","article-title":"A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology","volume":"25","author":"Metzler","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2014.09.006_bib19","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1038\/sj.emboj.7600760","article-title":"MLL fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis","volume":"24","author":"Drynan","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2014.09.006_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1535-6108(03)00019-9","article-title":"MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice","volume":"3","author":"So","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib21","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/sj.onc.1206104","article-title":"The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid\/myeloid cell","volume":"22","author":"Zeisig","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2014.09.006_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","article-title":"H3K79 methylation profiles define murine and human MLL-AF4 leukemias","volume":"14","author":"Krivtsov","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib23","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1139851","article-title":"Modeling the initiation and progression of human acute leukemia in mice","volume":"316","author":"Barabe","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.exphem.2014.09.006_bib24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccr.2008.04.020","article-title":"Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia","volume":"13","author":"Wei","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib25","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1182\/blood-2010-12-322230","article-title":"Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia","volume":"117","author":"Montes","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib26","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/sj.leu.2404342","article-title":"The MLL-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice","volume":"20","author":"Kong","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.09.006_bib27","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1073\/pnas.91.13.6236","article-title":"ALL-1 partial duplication in acute leukemia","volume":"91","author":"Schichman","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2014.09.006_bib28","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2012-03-415067","article-title":"MLL partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias","volume":"120","author":"Zorko","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib29","first-page":"122","article-title":"Modeling and targeting MLL-PTD\/RUNX1 related MDS\/AML in mouse","author":"Zhang","year":"2013","journal-title":"Blood Abstract"},{"key":"10.1016\/j.exphem.2014.09.006_bib30","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2010.30.7926","article-title":"RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group","volume":"29","author":"Gaidzik","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2014.09.006_bib31","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1172\/JCI25546","article-title":"MLL partial tandem duplication induces aberrant Hox expression in\u00a0vivo via specific epigenetic alterations","volume":"116","author":"Dorrance","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2014.09.006_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccr.2008.05.003","article-title":"Menin critically links MLL proteins with LEDGF on cancer-associated target genes","volume":"14","author":"Yokoyama","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib33","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1158\/0008-5472.CAN-06-2369","article-title":"Interaction of MLL amino terminal sequences with menin is required for transformation","volume":"67","author":"Caslini","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.09.006_bib34","first-page":"4417","article-title":"Mutation of the MENIN gene in sporadic pancreatic endocrine tumors","volume":"58","author":"Wang","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.09.006_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","article-title":"The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis","volume":"123","author":"Yokoyama","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"13","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib37","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1093\/nar\/gkt074","article-title":"Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes","volume":"41","author":"Eidahl","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2014.09.006_bib38","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/leu.2013.10","article-title":"Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF\/p75)","volume":"27","author":"Mereau","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.09.006_bib39","doi-asserted-by":"crossref","first-page":"31742","DOI":"10.1074\/jbc.M111.258186","article-title":"Crystal structure of menin reveals binding site for mixed lineage leukemia (MLL) protein","volume":"286","author":"Murai","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2014.09.006_bib40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature10806","article-title":"The same pocket in menin binds both MLL and JUND but has opposite effects on transcription","volume":"482","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.09.006_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nchembio.773","article-title":"Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia","volume":"8","author":"Grembecka","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.exphem.2014.09.006_bib42","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1182\/blood-2012-05-429274","article-title":"Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia","volume":"120","author":"Shi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib43","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood-2013-03-486647","article-title":"Distinct pathways regulated by menin and by MLL1 in hematopoietic stem cells and developing B cells","volume":"122","author":"Li","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib44","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1182\/blood-2010-12-324699","article-title":"MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome","volume":"117","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib45","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1128\/MCB.24.23.10470-10478.2004","article-title":"Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein","volume":"24","author":"Ayton","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2014.09.006_bib46","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1073\/pnas.1436338100","article-title":"MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein","volume":"100","author":"Xia","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2014.09.006_bib47","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/onc.2008.443","article-title":"Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2","volume":"28","author":"Bach","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2014.09.006_bib48","doi-asserted-by":"crossref","first-page":"29901","DOI":"10.1074\/jbc.M113.474858","article-title":"Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia","volume":"288","author":"Risner","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2014.09.006_bib49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nsmb.1714","article-title":"Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia","volume":"17","author":"Cierpicki","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.exphem.2014.09.006_bib50","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2010.05.011","article-title":"Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis","volume":"38","author":"Milne","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ccr.2010.04.012","article-title":"The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis","volume":"17","author":"Muntean","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.molcel.2005.10.004","article-title":"From transcription to mRNA: PAF provides a new path","volume":"20","author":"Rosonina","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.09.025","article-title":"Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation","volume":"20","author":"Zhu","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib54","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1182\/blood-2013-02-486977","article-title":"MLL fusion protein-driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction","volume":"122","author":"Muntean","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib55","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1073\/pnas.1301045110","article-title":"Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2014.09.006_bib56","doi-asserted-by":"crossref","first-page":"10187","DOI":"10.1093\/nar\/gks820","article-title":"Promoters active in interphase are bookmarked during mitosis by ubiquitination","volume":"40","author":"Arora","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2014.09.006_bib57","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.febslet.2011.07.034","article-title":"RNF20-RNF40: A ubiquitin-driven link between gene expression and the DNA damage response","volume":"585","author":"Shiloh","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.exphem.2014.09.006_bib58","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1242\/dev.033902","article-title":"Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice","volume":"136","author":"Schuettengruber","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.exphem.2014.09.006_bib59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/blood-2005-12-5014","article-title":"c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells","volume":"108","author":"Hess","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood-2011-03-341081","article-title":"Identification and characterization of Hoxa9 binding sites in hematopoietic cells","volume":"119","author":"Huang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib61","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1101\/gad.17269211","article-title":"An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance","volume":"25","author":"Zuber","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2014.09.006_bib62","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1128\/MCB.21.7.2249-2258.2001","article-title":"MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein","volume":"21","author":"Ernst","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2014.09.006_bib63","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jmb.2005.09.059","article-title":"Structural basis for cooperative transcription factor binding to the CBP coactivator","volume":"355","author":"De Guzman","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.exphem.2014.09.006_bib64","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI38030","article-title":"c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis","volume":"120","author":"Jin","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2014.09.006_bib65","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2012.08.028","article-title":"Blockade of miR-150 maturation by MLL-fusion\/MYC\/LIN-28 is required for MLL-associated leukemia","volume":"22","author":"Jiang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib66","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1158\/1541-7786.MCR-13-0002-T","article-title":"miR-150 blocks MLL-AF9\u2212associated leukemia through oncogene repression","volume":"11","author":"Bousquet","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.exphem.2014.09.006_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1615\/CritRevOncog.v16.i1-2.50","article-title":"CREB and leukemogenesis","volume":"16","author":"Cho","year":"2011","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.exphem.2014.09.006_bib68","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ccr.2010.04.024","article-title":"GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis","volume":"17","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib69","first-page":"535","article-title":"All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders","volume":"90","author":"Rowley","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib70","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1093\/emboj\/19.17.4655","article-title":"Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia","volume":"19","author":"Lavau","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2014.09.006_bib71","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.emboj.7600521","article-title":"Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease","volume":"24","author":"Wang","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2014.09.006_bib72","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1387\/ijdb.103106gs","article-title":"Hematopoietic stem cell emergence in the conceptus and the role of Runx1","volume":"54","author":"Swiers","year":"2010","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.exphem.2014.09.006_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1615\/CritRevOncog.v16.i1-2.80","article-title":"RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making","volume":"16","author":"Mangan","year":"2011","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.exphem.2014.09.006_bib74","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1182\/blood-2009-05-223784","article-title":"AML1\/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations","volume":"114","author":"Tang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib75","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Network TCGAR","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.09.006_bib76","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood-2010-10-315440","article-title":"Loss of AML1\/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF","volume":"118","author":"Nishimoto","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib77","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1172\/JCI68557","article-title":"Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells","volume":"123","author":"Goyama","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2014.09.006_bib78","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib79","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1101\/gad.1741408","article-title":"Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia","volume":"22","author":"Guenther","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2014.09.006_bib80","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.celrep.2012.12.016","article-title":"RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction","volume":"3","author":"Wilkinson","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2014.09.006_bib81","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.molcel.2011.11.032","article-title":"Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors","volume":"45","author":"Yu","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib82","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1182\/blood-2010-11-317909","article-title":"The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS\/AML-associated RUNX1\/AML1 mutations","volume":"118","author":"Huang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib83","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc2876","article-title":"Covalent histone modifications\u2013miswritten, misinterpreted and mis-erased in human cancers","volume":"10","author":"Chi","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2014.09.006_bib84","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccr.2009.12.040","article-title":"A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription","volume":"17","author":"Yokoyama","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molcel.2010.01.026","article-title":"AFF4, a component of the ELL\/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia","volume":"37","author":"Lin","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib86","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrg3293","article-title":"Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans","volume":"13","author":"Adelman","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.exphem.2014.09.006_bib87","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/hmg\/ddl444","article-title":"The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling","volume":"16","author":"Bitoun","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.exphem.2014.09.006_bib88","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cell.2005.02.020","article-title":"hDOT1L links histone methylation to leukemogenesis","volume":"121","author":"Okada","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib89","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1101\/gad.2057811","article-title":"The diverse functions of Dot1 and H3K79 methylation","volume":"25","author":"Nguyen","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2014.09.006_bib90","doi-asserted-by":"crossref","first-page":"E636","DOI":"10.1073\/pnas.1107107108","article-title":"Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin","volume":"108","author":"He","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.exphem.2014.09.006_bib91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccr.2011.06.009","article-title":"Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor","volume":"20","author":"Daigle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib92","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2012-11-465120","article-title":"Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l","volume":"121","author":"Deshpande","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib93","doi-asserted-by":"crossref","unstructured":"K\u00fchn MWM, Hadler M, Daigle SR, et\u00a0al. Myeloid leukemia cells with MLL partial tandem duplication are sensitive to pharmacological inhibition of the H3K79 methyltransferase DOT1L ASH Abstract.\u00a02013.","DOI":"10.1182\/blood.V122.21.1256.1256"},{"key":"10.1016\/j.exphem.2014.09.006_bib94","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00018-009-0010-x","article-title":"The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans","volume":"66","author":"Wolf","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.exphem.2014.09.006_bib95","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/ncb1642","article-title":"Protein arginine-methyltransferase-dependent oncogenesis","volume":"9","author":"Cheung","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2014.09.006_bib96","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1038\/sj.onc.1210760","article-title":"Hox genes in hematopoiesis and leukemogenesis","volume":"26","author":"Argiropoulos","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2014.09.006_bib97","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1101\/gad.1111603","article-title":"Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9","volume":"17","author":"Ayton","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2014.09.006_bib98","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2003-07-2582","article-title":"Hoxa9 influences the phenotype but not the incidence of MLL-AF9 fusion gene leukemia","volume":"103","author":"Kumar","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib99","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1182\/blood-2003-10-3722","article-title":"Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9","volume":"103","author":"So","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/blood-2005-06-2245","article-title":"Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells","volume":"108","author":"Bijl","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib101","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/dvdy.24016","article-title":"Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates","volume":"243","author":"Longobardi","year":"2014","journal-title":"Dev Dyn"},{"key":"10.1016\/j.exphem.2014.09.006_bib102","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/blood-2008-06-163287","article-title":"A role for MEIS1 in MLL-fusion gene leukemia","volume":"113","author":"Kumar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib103","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1101\/gad.1602107","article-title":"Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential","volume":"21","author":"Wong","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2014.09.006_bib104","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2012-07-442004","article-title":"PBX3 is an important cofactor of HOXA9 in leukemogenesis","volume":"121","author":"Li","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib105","doi-asserted-by":"crossref","first-page":"12000","DOI":"10.1073\/pnas.1301278110","article-title":"An MLL-dependent network sustains hematopoiesis","volume":"10","author":"Artinger","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2014.09.006_bib106","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00018-012-1144-9","article-title":"The Eyes Absent proteins in development and disease","volume":"70","author":"Tadjuidje","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.exphem.2014.09.006_bib107","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbrc.2012.08.048","article-title":"Regulation of HOXA9 activity by predominant expression of DACH1 against C\/EBPalpha and GATA-1 in myeloid leukemia with MLL-AF9","volume":"426","author":"Lee","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2014.09.006_bib108","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood-2008-04-154310","article-title":"Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization","volume":"113","author":"Popovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib109","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3324\/haematol.2010.023481","article-title":"Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia","volume":"95","author":"Schotte","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2014.09.006_bib110","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.exphem.2013.02.006","article-title":"Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia","volume":"41","author":"Beachy","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.09.006_bib111","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ncomms1681","article-title":"miR-196b directly targets both HOXA9\/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia","volume":"3","author":"Li","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2014.09.006_bib112","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1172\/JCI66005","article-title":"Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity","volume":"124","author":"Velu","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2014.09.006_bib113","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nature01973","article-title":"cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox genes","volume":"425","author":"Davidson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.09.006_bib114","doi-asserted-by":"crossref","first-page":"7756","DOI":"10.1073\/pnas.0708951105","article-title":"Cdx gene deficiency compromises embryonic hematopoiesis in the mouse","volume":"105","author":"Wang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2014.09.006_bib115","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI30182","article-title":"The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis","volume":"117","author":"Scholl","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2014.09.006_bib116","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3324\/haematol.2010.023168","article-title":"Cdx4 is dispensable for murine adult hematopoietic stem cells but promotes MLL-AF9\u2212mediated leukemogenesis","volume":"95","author":"Koo","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2014.09.006_bib117","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.mt.6300372","article-title":"The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy","volume":"16","author":"Metais","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.exphem.2014.09.006_bib118","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2009.26.0646","article-title":"High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities","volume":"28","author":"Groschel","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2014.09.006_bib119","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1182\/blood-2011-11-393827","article-title":"EVI1 is critical for the pathogenesis of a subset of MLL-AF9\u2212rearranged AMLs","volume":"119","author":"Bindels","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib120","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood-2011-02-334680","article-title":"PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib121","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1182\/blood-2009-07-234310","article-title":"Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells","volume":"117","author":"Arai","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib122","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.stem.2008.06.002","article-title":"Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells","volume":"3","author":"Goyama","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib123","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1182\/blood-2012-08-453662","article-title":"Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia","volume":"122","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib124","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/leu.2012.363","article-title":"Cell of origin determines clinically relevant subtypes of MLL-rearranged AML","volume":"27","author":"Krivtsov","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.09.006_bib125","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2008-05-158196","article-title":"Homing and invasiveness of MLL\/ENL leukemic cells is regulated by MEF2C","volume":"114","author":"Schwieger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib126","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.09.006_bib127","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccr.2013.05.004","article-title":"In\u00a0Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling","volume":"24","author":"Miller","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib128","first-page":"6480","article-title":"MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation","volume":"61","author":"Schreiner","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.09.006_bib129","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.molcel.2009.12.001","article-title":"A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit","volume":"36","author":"Blobel","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.09.006_bib131","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Zuber","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.09.006_bib132","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/bfgp\/elt007","article-title":"Bromodomains as therapeutic targets in cancer","volume":"12","author":"Barbieri","year":"2013","journal-title":"Brief Funct Genomics"},{"key":"10.1016\/j.exphem.2014.09.006_bib133","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0037-1963(03)00196-3","article-title":"MLL-rearranged leukemias: insights from gene expression profiling","volume":"40","author":"Armstrong","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2014.09.006_bib134","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.leu.2404951","article-title":"MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment","volume":"22","author":"Stubbs","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.09.006_bib135","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.4049\/jimmunol.0904203","article-title":"Hoxa9 regulates Flt3 in lymphohematopoietic progenitors","volume":"185","author":"Gwin","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2014.09.006_bib136","doi-asserted-by":"crossref","first-page":"e72261","DOI":"10.1371\/journal.pone.0072261","article-title":"Flt3 does not play a critical role in murine myeloid leukemias induced by MLL fusion genes","volume":"8","author":"Albouhair","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2014.09.006_bib137","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.exphem.2013.11.008","article-title":"Differential requirement for wild-type Flt3 in leukemia-initiation among mouse models of human leukemia","volume":"42","author":"Kamezaki","year":"2014","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.09.006_bib138","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3324\/haematol.2012.067983","article-title":"Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants","volume":"98","author":"Driessen","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2014.09.006_bib139","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood-2008-01-132316","article-title":"RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia","volume":"113","author":"Kim","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib140","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/leu.2009.177","article-title":"Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation","volume":"23","author":"Ono","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.09.006_bib141","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/leu.2011.15","article-title":"Activated K-Ras protein accelerates human MLL\/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model","volume":"25","author":"Tamai","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.09.006_bib142","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.exphem.2010.03.014","article-title":"Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins","volume":"38","author":"Ng","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.09.006_bib143","doi-asserted-by":"crossref","first-page":"14442","DOI":"10.1073\/pnas.0703211104","article-title":"ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias","volume":"104","author":"Nakanishi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2014.09.006_bib144","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1182\/blood-2013-09-525741","article-title":"MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia","volume":"124","author":"Manara","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib145","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","article-title":"The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.exphem.2014.09.006_bib146","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ccr.2010.10.032","article-title":"beta-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells","volume":"18","author":"Yeung","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib147","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jcb.22467","article-title":"Wnt signaling in hematopoiesis: crucial factors for self-renewal, proliferation, and cell fate decisions","volume":"109","author":"Staal","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.exphem.2014.09.006_bib148","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib149","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/ncomms1680","article-title":"An intrinsically labile alpha-helix abutting the BCL9-binding site of beta-catenin is required for its inhibition by carnosic acid","volume":"3","author":"de la Roche","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2014.09.006_bib150","first-page":"4058","article-title":"MLL1, a H3K4 methyltransferase, regulates the TNFalpha-stimulated activation of genes downstream of NF-kappaB","volume":"125","author":"Wang","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.exphem.2014.09.006_bib151","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.immuni.2012.02.016","article-title":"The histone methyltransferase Wbp7 controls macrophage function through GPI glycolipid anchor synthesis","volume":"36","author":"Austenaa","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2014.09.006_bib152","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccr.2013.08.019","article-title":"Epigenetic roles of MLL oncoproteins are dependent on NF-kappaB","volume":"24","author":"Kuo","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib153","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1084\/jem.20130932","article-title":"Initiation of MLL-rearranged AML is dependent on C\/EBPalpha","volume":"211","author":"Ohlsson","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2014.09.006_bib154","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/leu.2013.384","article-title":"PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS\/HOX pathway","volume":"28","author":"Zhou","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.09.006_bib155","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrc2931","article-title":"Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins","volume":"10","author":"Mills","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2014.09.006_bib156","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nrm3230","article-title":"Trithorax group proteins: switching genes on and keeping them active","volume":"12","author":"Schuettengruber","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2014.09.006_bib157","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood-2011-11-394932","article-title":"Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia","volume":"120","author":"Tanaka","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib158","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1073\/pnas.1202258109","article-title":"Polycomb repressive complex 2 is required for MLL-AF9 leukemia","volume":"109","author":"Neff","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2014.09.006_bib159","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.stem.2013.10.001","article-title":"Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner","volume":"14","author":"Xie","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib160","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/onc.2012.110","article-title":"The Polycomb complex PRC2\u00a0supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia","volume":"32","author":"Shi","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2014.09.006_bib161","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nchembio.1331","article-title":"Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer","volume":"9","author":"Kim","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.exphem.2014.09.006_bib162","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/leu.2011.85","article-title":"Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells","volume":"25","author":"Yuan","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.09.006_bib163","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.stem.2011.05.004","article-title":"Functional crosstalk between Bmi1 and MLL\/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells","volume":"8","author":"Smith","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib164","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2011.09.008","article-title":"CBX8, a polycomb group protein, is essential for MLL-AF9\u2212induced leukemogenesis","volume":"20","author":"Tan","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib165","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.celrep.2013.03.038","article-title":"MLL-ENL inhibits polycomb repressive complex 1 to achieve efficient transformation of hematopoietic cells","volume":"3","author":"Maethner","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2014.09.006_bib166","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1097-2765(02)00740-2","article-title":"ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation","volume":"10","author":"Nakamura","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib167","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccr.2012.03.014","article-title":"The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells","volume":"21","author":"Harris","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib168","doi-asserted-by":"crossref","first-page":"e00633","DOI":"10.7554\/eLife.00633","article-title":"Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation","volume":"2","author":"Kerenyi","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.exphem.2014.09.006_bib169","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2009.12.034","article-title":"MLL-AF9\u2212induced leukemogenesis requires coexpression of the wild-type MLL allele","volume":"17","author":"Thiel","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib170","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2014.04.015","article-title":"The histone methyltransferase activity of MLL1 is dispensable for hematopoiesis and leukemogenesis","volume":"7","author":"Mishra","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2014.09.006_bib171","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/leu.2013.42","article-title":"The AAA ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis","volume":"27","author":"Osaki","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.09.006_bib172","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1101\/gad.232710.113","article-title":"Role of SWI\/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation","volume":"27","author":"Shi","year":"2013","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2014.09.006_bib173","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejca.2012.07.013","article-title":"Absence of global hypomethylation in promoter hypermethylated Mixed Lineage Leukaemia-rearranged infant acute lymphoblastic leukaemia","volume":"49","author":"Stumpel","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.exphem.2014.09.006_bib174","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2009-09-243634","article-title":"Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting","volume":"115","author":"Schafer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib175","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1182\/blood-2013-06-507426","article-title":"Eradicating acute myeloid leukemia in a MLLPTD\/wt:Flt3ITD\/wt murine model: a path to novel therapeutic approaches for human disease","volume":"122","author":"Bernot","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.09.006_bib176","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1101\/gad.184341.111","article-title":"Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains","volume":"26","author":"Trowbridge","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2014.09.006_bib177","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ng.463","article-title":"DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction","volume":"41","author":"Broske","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2014.09.006_bib178","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cell.2011.03.022","article-title":"Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain","volume":"145","author":"Guo","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.09.006_bib179","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.1073\/pnas.1310656110","article-title":"TET1 plays an essential oncogenic role in MLL-rearranged leukemia","volume":"110","author":"Huang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14006766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14006766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:32:01Z","timestamp":1759566721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X14006766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":179,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0301472X14006766"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2014.09.006","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2014.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}